No Detail Found!

Impact of Diabetes on Mechanisms of Immunity against Mycobacterium Tuberculosis.

Author(s)
Shoaib Rao The Aga Khan University, Karachi, Pakistan
Maryam Rahim The Aga Khan University, Karachi, Pakistan
Kiran Iqbal The Aga Khan University, Karachi, Pakistan
Fatima Haroon The Aga Khan University, Karachi, Pakistan
Zahra Hasan The Aga Khan University, Karachi, Pakistan
Abstract
Tuberculosis (TB), caused by infection with mycobacterium tuberculosis, is a major source of morbidity and mortality in Pakistan. Diabetes caused by imbalance in glycaemic control is also highly prevalent in the country. The co-incidence of both diseases results in worsening outcomes of TB, making treatment and management more difficult. Both innate and adaptive arms of the host immune response are required for protection against M. tuberculosis infection. Host immunity is modified in diabetes mellitus type 2 where key pathways such as, the T cell driven interferon-gamma responses to M. tuberculosis antigens and other T cell and macrophage activating cytokines are suppressed. This makes diabetes with TB a more severe disease and results in worse treatment outcomes. Effective coordination between T cells and host macrophages is required for control of TB infection. Therefore, early identification of diabetes and management of hyperglycaemia during TB treatment is essential for favourable outcomes.
Publication Details
Page(s) 94-98
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 69, Issue: 1, Year: 2019

Request the full text from PASTIC

Keywords
Diabetes, Tuberculosis, Latent TB, Host immunity
References
RestrepoBI,SchlesingerLS, 2014.Impact of diabetes on the natural history of tuberculosis,Diabetes Res Clin Pract 106 191 -9
3. Jimenez CME, Cruz HLP, Garcia GL, Ferreyra-Reyes L, Delgado-Sanchez G, Bobadilla-DVM, et al. Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes. Thorax. 2013; 68:214-20
OrmeI., 1993.Immunity to mycobacteria,Curr Opin Immunol 5 497 -502
GuiradoE,SchlesingerLS, .Modeling the Mycobacterium tuberculosis Granuloma - the Critical Battlefield in Host Immunity 6, -
RomeroMM,BasileJI,LopezB,RitaccoV,BarreraL,Sasiain MdelC, 2014.Outbreaks of Mycobacterium tuberculosis MDR strains differentially induce neutrophil respiratory burst involving lipid rafts, p38 MAPK and Syk,BMC Infect Dis 14 262 -
EruslanovEB,LyadovaIV,KondratievaTK,MajorovKB,ScheglovIV,OrlovaMO, 2005.Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice,Infect Immun 73 1744 -53
NauGJ,RichmonJFL,SchlesingerA,JenningsEG,LanderES,YoungRA, 2002.Human macrophage activation programs activated by bacterial pathogens,Proc Natl Acad Sci U S A 99 1503 -8
AndreasenAS,Pedersen-SkovsgaardT,BergRM,SvendsenKD,Feldt-RasmussenB,PedersenBK, .Type 2 diabetes mellitus is associated with impaired cytokine response and adhesion molecule expression in human endotoxemia,Intensive Care Med. -
VankayalapatiR,GargA,PorgadorA,GriffithDE,KlucarP,SafiH, 2005.Role of NK Cell-Activating Receptors and Their Ligands in the Lysis of Mononuclear Phagocytes Infected with an Intracellular Bacterium,J Immunol 175 4611 -7
NK Cells Regulate CD8+ T Cell Effector, 2003.Function in Response to an Intracellular Pathogen,J Immunol 172 130 -7
Mihret A., 2012.The role of dendritic cells in Mycobacterium tuberculosis infection,Virulence 3 654 -9
BalboaL,KviatcovskyD,SchierlohP,GarciaM,de la BarreraS,SasiainMDC, 2016.Monocyte-derived dendritic cells early exposed to Mycobacterium tuberculosis induce an enhanced T helper 17 response and transfer mycobacterial antigens,Int J Med Microbiol 306 541 -53
LyadovaIV,PanteleevAV,Biomarkers. MediatorsInflamm, 2015.Th1 and Th17 Cells in Tuberculosis: Protection, Pathology, and, 854507 -
SainiV., 2010.Molecular mechanisms of insulin resistance in type 2 diabetes mellitus,World J Diabetes 1 68 -75
DonathMY,ShoelsonSE, 2011.Type 2 diabetes as an inflammatory disease,Nat Rev Immunol 11 98 -107
PickupJC, 2004.Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes,Diabetes Care 27 813 -23
SekharRV,McKaySV,PatelSG,GuthikondaAP,ReddyVT,BalasubramanyamA, 2011.Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine,Diabetes Care 34 162 -7
2009.Normalization of obesity-associated insulin resistance through immunotherapy,Nat Med 15 921 -9
KumariP,MeenaLS, 2014.Factors affecting susceptibility to Mycobacterium tuberculosis: a close view of immunological defence mechanism,Appl Biochem Biotechnol 174 2663 -73
Kumar NathellaP,BabuS., 2017.Influence of diabetes mellitus on immunity to human tuberculosis,Immunology 152 13 -24
Alba-LoureiroTC,HirabaraSM,MendoncaJR,CuriR,Pithon-CuriTC, 2006.Diabetes causes marked changes in function and metabolism of rat neutrophils,J Endocrinol 188 295 -303
2012.Glutathione reductase facilitates host defense by sustaining phagocytic oxidative burst and promoting the development of neutrophil extracellular traps,J Immunol 188 2316 -27
2012.Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria,J Clin Invest 122 2289 -300
VallerskogT,MartensGW,KornfeldH, 2010.Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis,J Immunol 184 6275 -82
2011.High glucose disrupts oligosaccharide recognition function via competitive inhibition: a potential mechanism for immune dysregulation in diabetes mellitus,Immunobiology 216 126 -31
GuptaS,MarathaA,SiednienkoJ,NatarajanA,GajanayakeT,HoashiS, .Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications,Sci Rep. -
KumarNP,SridharR,BanurekhaVV,JawaharMS,NutmanTB,BabuS., 2013.Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus,J Infect Dis 208 739 -48
RedfordPS,BoonstraA,ReadS,PittJ,GrahamC,StavropoulosE, 2010.Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung,Eur J Immunol 40 2200 -10
Al-AttiyahRJ,MustafaAS, 2009.Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guerin (BCG)-vaccinated healthy subjects,Clin Exp Immunol 158 64 -73
StalenhoefJE,AlisjahbanaB,NelwanEJ,van der Ven-JongekrijgJ,OttenhoffTH,van der MeerJW, 2008.The role of interferongamma in the increased tuberculosis risk in type 2 diabetes mellitus,Eur J Clin Microbiol Infect Dis 27 97 -103
Panee J. Monocyte, 2012.Chemoattractant Protein 1 (MCP-1) in obesity and diabetes,Cytokine 60 1 -12
EndocrinolMetab Clin North Am, 2017., 46 1061 -94
.Change in serum CXCL10 levels during anti-tuberculosis treatment depends on vitamin D status [Short Communication], -
Int J Tuberc Lung Dis, 2014., 18 466 -9
HerreraMT,GonzalezY,Hernandez-SanchezF,Fabian-San MiguelG,TorresM, .Low serum vitamin D levels in type 2 diabetes patients are associated with decreased mycobacterial activity, -
BMC InfectDis, 2017., 17 610 -
InfectImmun, 2009., 77 4690 -5
Rivas-SantiagoB,Hernandez-PandoR,CarranzaC,JuarezE,ContrerasJL,Aguilar-LeonD, 2008.Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells,Infect Immun 76 935 -41
Gonzalez-CurielI,Castaneda-DelgadoJ,Lopez-LopezN,AraujoZ,Hernandez-PandoR,Gandara-JassoB, 2011.Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus,Hum Immunol 72 656 -62
KumarNP,MoideenK,DollaC,KumaranP,BabuS., 2017.Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection,PLoS One 12 e0178000 -
KumarNP,BanurekhaVV,NairD,SridharR,KornfeldH,NutmanTB, 2014.Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis,PLoS One 9 e112108 -
KariminiaA,SharifniaZ,ZghakhaniA,BanifazlM,EslamifarA,HazratiM, 2009.Comparison of QuantiFERON TB-G test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population,J Eval Clin Prac 15 148 -51
KabeerBSA,RamanB,ThomasA,PerumalV,RajaA, 2010.Role of QuantiFERON-TB Gold, Interferon gamma, inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis,PLoS One 5 e9051 -
DenkingerCM,DhedaK,PaiM., 2011.Guidelines on interferon-gamma release assays for tuberculosis infection: concordance, discordance or confusion?,Clin Microbiol Infect 17 806 -14
ChegouNN,BlackGF,KiddM,van HeldenPD,WalzlG, 2009.Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report,BMC Pulm Med 9 21 -
KumarNP,SridharR,BanurekhaVV,JawaharMS,FayMP,NutmanTB, .Type 2 diabetes mellitus coincident with pulmonary tuberculosis is associated with heightened systemic type 1, type 17, and other proinflammatory cytokines,Ann Am Thorac Soc. -
0

Citations

0

Downloads

79

Views